167 related articles for article (PubMed ID: 9824646)
21. Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas.
Lakka SS; Gondi CS; Dinh DH; Olivero WC; Gujrati M; Rao VH; Sioka C; Rao JS
J Biol Chem; 2005 Jun; 280(23):21882-92. PubMed ID: 15824107
[TBL] [Abstract][Full Text] [Related]
22. Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator.
Mahanivong C; Yu J; Huang S
Mol Carcinog; 2007 Mar; 46(3):165-75. PubMed ID: 17186542
[TBL] [Abstract][Full Text] [Related]
23. Urokinase-type plasminogen activator and its receptor in colorectal cancer: independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets.
Yang JL; Seetoo Dq; Wang Y; Ranson M; Berney CR; Ham JM; Russell PJ; Crowe PJ
Int J Cancer; 2000 Sep; 89(5):431-9. PubMed ID: 11008205
[TBL] [Abstract][Full Text] [Related]
24. Regulation of urokinase plasminogen activator/plasmin-mediated invasion of melanoma cells by the integrin vitronectin receptor alphaVbeta3.
Khatib AM; Nip J; Fallavollita L; Lehmann M; Jensen G; Brodt P
Int J Cancer; 2001 Feb; 91(3):300-8. PubMed ID: 11169951
[TBL] [Abstract][Full Text] [Related]
25. A novel role for the urokinase-type plasminogen activator receptor in apoptosis of malignant gliomas.
Kin Y; Chintala SK; Go Y; Sawaya R; Mohanam S; Kyritsis AP; Rao JS
Int J Oncol; 2000 Jul; 17(1):61-5. PubMed ID: 10853019
[TBL] [Abstract][Full Text] [Related]
26. Altered in vitro spreading and cytoskeletal organization in human glioma cells by downregulation of urokinase receptor.
Chintala SK; Mohanam S; Go Y; Venkaiah B; Sawaya R; Gokaslan ZL; Rao JS
Mol Carcinog; 1997 Dec; 20(4):355-65. PubMed ID: 9433480
[TBL] [Abstract][Full Text] [Related]
27. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
[TBL] [Abstract][Full Text] [Related]
28. Heregulin regulation of urokinase plasminogen activator and its receptor: human breast epithelial cell invasion.
Mazumdar A; Adam L; Boyd D; Kumar R
Cancer Res; 2001 Jan; 61(1):400-5. PubMed ID: 11196194
[TBL] [Abstract][Full Text] [Related]
29. Intraperitoneal injection of a hairpin RNA-expressing plasmid targeting urokinase-type plasminogen activator (uPA) receptor and uPA retards angiogenesis and inhibits intracranial tumor growth in nude mice.
Gondi CS; Lakka SS; Dinh DH; Olivero WC; Gujrati M; Rao JS
Clin Cancer Res; 2007 Jul; 13(14):4051-60. PubMed ID: 17634529
[TBL] [Abstract][Full Text] [Related]
30. Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis.
He Y; Liu XD; Chen ZY; Zhu J; Xiong Y; Li K; Dong JH; Li X
Clin Cancer Res; 2007 Jun; 13(11):3115-24. PubMed ID: 17545513
[TBL] [Abstract][Full Text] [Related]
31. The effects of cyclooxygenase2-prostaglandinE2 pathway on Helicobacter pylori-induced urokinase-type plasminogen activator system in the gastric cancer cells.
Iwamoto J; Mizokami Y; Takahashi K; Matsuoka T; Matsuzaki Y
Helicobacter; 2008 Jun; 13(3):174-82. PubMed ID: 18466392
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of the urokinase-type plasminogen activator receptor through inhibition of translation by antisense oligonucleotide suppresses invasion of human glioblastoma cells.
Mohan PM; Lakka SS; Mohanam S; Kin Y; Sawaya R; Kyritsis AP; Nicolson GL; Rao JS
Clin Exp Metastasis; 1999; 17(7):617-21. PubMed ID: 10845561
[TBL] [Abstract][Full Text] [Related]
33. siRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells.
Subramanian R; Gondi CS; Lakka SS; Jutla A; Rao JS
Int J Oncol; 2006 Apr; 28(4):831-9. PubMed ID: 16525631
[TBL] [Abstract][Full Text] [Related]
34. CD44 stimulation by fragmented hyaluronic acid induces upregulation of urokinase-type plasminogen activator and its receptor and subsequently facilitates invasion of human chondrosarcoma cells.
Kobayashi H; Suzuki M; Kanayama N; Nishida T; Takigawa M; Terao T
Int J Cancer; 2002 Dec; 102(4):379-89. PubMed ID: 12402308
[TBL] [Abstract][Full Text] [Related]
35. Urokinase-mediated posttranscriptional regulation of urokinase-receptor expression in non small cell lung carcinoma.
Montuori N; Mattiello A; Mancini A; Taglialatela P; Caputi M; Rossi G; Ragno P
Int J Cancer; 2003 Jun; 105(3):353-60. PubMed ID: 12704669
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of urokinase receptor in breast cancer cells results in increased tumor invasion, growth and metastasis.
Xing RH; Rabbani SA
Int J Cancer; 1996 Jul; 67(3):423-9. PubMed ID: 8707419
[TBL] [Abstract][Full Text] [Related]
37. Urokinase-type plasminogen activator up-regulates the expression of its cellular receptor through a post-transcriptional mechanism.
Montuori N; Mattiello A; Mancini A; Santoli M; Taglialatela P; Caputi M; Rossi G; Ragno P
FEBS Lett; 2001 Nov; 508(3):379-84. PubMed ID: 11728456
[TBL] [Abstract][Full Text] [Related]
38. Proteolysis and invasiveness of brain tumors: role of urokinase-type plasminogen activator receptor.
Mohanam S; Sawaya RE; Yamamoto M; Bruner JM; Nicholson GL; Rao JS
J Neurooncol; 1994; 22(2):153-60. PubMed ID: 7745467
[TBL] [Abstract][Full Text] [Related]
39. Urokinase induces receptor mediated brain tumor cell migration and invasion.
MacDonald TJ; DeClerck YA; Laug WE
J Neurooncol; 1998 Dec; 40(3):215-26. PubMed ID: 10066093
[TBL] [Abstract][Full Text] [Related]
40. In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion.
Ossowski L; Clunie G; Masucci MT; Blasi F
J Cell Biol; 1991 Nov; 115(4):1107-12. PubMed ID: 1659573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]